THERAPY Risk of metformin use in patients with T2DM and advanced CKD

被引：9
|
作者：
Schernthaner, Guntram [1 ]
Schernthaner-Reiter, Marie Helene [2 ]
机构：
[1] Rudolfstiftung Hosp, Dept Med 1, A-1030 Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, A-1090 Vienna, Austria
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2015年 / 11卷 / 12期
关键词：
KIDNEY-DISEASE; MORTALITY;
D O I：
10.1038/nrendo.2015.132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In a new study published in The Lancet Diabetes & Endocrinology, metformin use is associated with significantly increased all-cause mortality in patients with type 2 diabetes mellitus and stage 5 chronic kidney disease (CKD). The findings support current recommendations that metformin should not be used in patients with stage 5 CKD.
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [31] Dietary factors in the risk of T2DM
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 537 - 537
  • [32] T2DM MODIFIES THE RELATIONSHIP BETWEEN CAC AND ADVERSE KIDNEY OUTCOME IN PATIENTS WITH CKD
    Yun, Hae-Ryong
    Han, Seung Hyeok
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I573 - I574
  • [33] Dietary factors in the risk of T2DM
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2020, 16 : 537 - 537
  • [34] Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
    Perez, Alfonso
    Zhao, Zhen
    Jacks, Randal
    Spanheimer, Robert
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2915 - 2923
  • [35] DEPRESSION AND SELF-MANAGEMENT BEHAVIORS OF PATIENTS WITH T2DM AND STAGE 3 CKD
    Sakraida, Teresa J.
    Terada, Masako
    Carron, Rebecca C.
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2010, 17 : 140 - 140
  • [36] Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
    Liu, Chen-Qian
    Sun, Jian-Xuan
    Xu, Jin-Zhou
    Qian, Xiao-Yuan
    Hong, Sen-Yuan
    Xu, Meng-Yao
    An, Ye
    Xia, Qi-Dong
    Hu, Jia
    Wang, Shao-Gang
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients
    [J]. Reactions Weekly, 2022, 1900 (1) : 6 - 6
  • [38] High adiponectin and reduced risk of T2DM in patients with STEMI
    Lindberg, S.
    Jensen, J. S.
    Pedersen, S. H.
    Galatius, S.
    Frystyk, J.
    Flyvbjerg, A.
    Bjerre, M.
    Mogelvang, R.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 393 - 393
  • [39] Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?
    Abdul-Ghani, Muhammad
    Jayyous, Amin
    Asaad, Nidal
    Helmy, Sherif
    Al-Suwaidi, Jassim
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (10)
  • [40] FERTILITY IN T1DM AND T2DM PATIENTS
    Ben Haroush, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A12 - A12
12345